Episurf Medical obtains further granted patent in the US

Episurf Medical has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent application covers Episurf Medical’s surgical drill guide with a functionality for depth adjustment.

LÄS MER


Episurf Medical obtains further granted patent in the US

Eurofins Digital Testing Selected by Zenterio for Next-Gen TV Service Validation

Eurofins Digital Testing, a global leader in end-to-end quality assurance (QA) and testing services, today announced it has been selected by Zenterio to automate monitoring of service availability.

LÄS MER


Eurofins Digital Testing Selected by Zenterio for Next-Gen TV Service Validation

Zenterio at NAB 2017 in Las Vegas

North America is the largest pay TV region on the world in terms of both subscribers and revenue. Despite this, pay TV operators are facing unprecedented challenges from alternative video platforms.

LÄS MER


Zenterio at NAB 2017 in Las Vegas

Xbrane Biopharma delivers first batch of Spherotide.

Xbrane Biopharma has delivered its first batch of Spherotide to its partner in the Middle East to a value of 7 MSEK. Xbrane expects shipment of at least two additional batches of similar size to its partner in the Middle East during 2017.

LÄS MER


Xbrane Biopharma delivers first batch of Spherotide.

Zenterio Reports Fourth Quarter

The fourth quarter has again been a busy one. Our greatest challenge in this quarter has been the large number of software releases for our main customers. We have now delivered more than 10 major software releases to the Deutsche Telekom Group.

LÄS MER


Zenterio Reports Fourth Quarter

Zenterio shows seamless multiscreen TV integration at CABSAT 2017

Zenterio, a leading television and multiscreen solutions provider, will showcase its technology portfolio for TV operators at CABSAT in Dubai, on March 21-23, 2017.

LÄS MER


Zenterio shows seamless multiscreen TV integration at CABSAT 2017

Xbrane Biopharma reports positive in-vitro biosimilarity data on Xlucane

Xbrane Biopharma has performed a comprehensive in-vitro biosimilarity study with several pilot scale R&D batches of Xlucane versus several batches of the reference product.

LÄS MER


Xbrane Biopharma reports positive in-vitro biosimilarity data on Xlucane

Zenterio launches updated website to support its focus on the complete solution

Last year we announced two new additions to our product portfolio: Audience – a powerful data analytics tool that allows operators to collect and analyze viewing data, and Engage – a platform.

LÄS MER


Zenterio launches updated website to support its focus on the complete solution

Stureplansgruppen och ADIA utvecklar hotellkoncept i nya Sturekvarteret

Abu Dhabi Investment Authority (”ADIA”) och Stureplansgruppen offentliggör idag ett samarbete där Stureplansgruppen får i uppdrag att utveckla och driva det nya hotellet för Sturekvarteret.

LÄS MER


Stureplansgruppen och ADIA utvecklar hotellkoncept i nya Sturekvarteret

Grand Escalier i Ericsson Globe

Nu kan vi äntligen berätta om årets stora restaurang- och barsatsning i Ericsson Globe. Den 25 februari öppnar vi Grand Escalier! Trivs du på Grand Escalier i Sturegallerian, kommer du att känna igen dig både i den franska menyn, vår bardel Esque, restaurangens design och förstås pulsen.

LÄS MER


Grand Escalier i Ericsson Globe

logo